These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23423363)

  • 1. Bone-destroying candida infection following left ventricular assist device explant.
    Seguchi O; Fujita T; Murata Y; Yanase M; Higashi M; Toda K; Nakatani T
    J Artif Organs; 2013 Jun; 16(2):258-62. PubMed ID: 23423363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida rib osteomyelitis: erythema and nodule in midline scar.
    Prevost N; English JC
    J Am Acad Dermatol; 2013 Oct; 69(4):e205-7. PubMed ID: 24034406
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.
    Krishnamoorthy A; Pokorney SD; Lewis RK; Daubert JP; Greenfield RA; Hegland DD; Milano CA; Rogers JG; Schroder JN; Patel CB; Piccini JP
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1199-205. PubMed ID: 24890850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful removal of a potentially lethal left atrial thrombus detected by transesophageal echocardiography following the removal of a left ventricular assist device inflow cannula.
    Chuang CC; Lee CC; Liao SW; Ting CK; Chu CC; Chan KH; Lin SM
    J Chin Med Assoc; 2012 Oct; 75(10):543-6. PubMed ID: 23089409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device.
    Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Ueno T; Kuratani T; Sawa Y
    Circ J; 2012; 76(2):372-6. PubMed ID: 22122967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and prognostic impact of left ventricular assist device-associated infections.
    Tattevin P; Flécher E; Auffret V; Leclercq C; Boulé S; Vincentelli A; Dambrin C; Delmas C; Barandon L; Veniard V; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Savouré A; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Bernard L; Bourguignon T; Eschalier R; D'Ostrevy N; Jouan J; Varlet E; Vanhuyse F; Blangy H; Martins RP; Galand V
    Am Heart J; 2019 Aug; 214():69-76. PubMed ID: 31174053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.
    Sacks J; Gonzalez-Stawinski GV; Hall S; Lima B; MacHannaford J; Dockery W; Cura M; Chamogeorgakis T
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):590-3. PubMed ID: 26223857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missing the blind spot in a HeartMate 3 LVAD outflow graft obstruction caused by fungal infection.
    Hoermandinger C; Schoenrath F; Stawowy P; Winkler D; Falk V; Potapov E; Just IA
    Artif Organs; 2022 Jan; 46(1):155-158. PubMed ID: 34605037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable LVAD infections: implications for permanent use of the device.
    McCarthy PM; Schmitt SK; Vargo RL; Gordon S; Keys TF; Hobbs RE
    Ann Thorac Surg; 1996 Jan; 61(1):359-65; discussion 372-3. PubMed ID: 8561605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.
    Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M
    Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for improving diagnosis of infection in patients on CF-LVAD: longing for more 'insights'.
    Dell'Aquila AM; Avramovic N; Mastrobuoni S; Motekallemi A; Wisniewski K; Scherer M; Sindermann JR; Wenning C
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):532-543. PubMed ID: 28977417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of left ventricular assist device-related infections.
    Bentz B; Hupcey JE; Polomano RC; Boehmer JP
    J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
    Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal left ventricular assist device endocarditis.
    Nurozler F; Argenziano M; Oz MC; Naka Y
    Ann Thorac Surg; 2001 Feb; 71(2):614-8. PubMed ID: 11235716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of left ventricular assist device inflow cannula position on thrombosis risk.
    Ghodrati M; Maurer A; Schlöglhofer T; Khienwad T; Zimpfer D; Beitzke D; Zonta F; Moscato F; Schima H; Aigner P
    Artif Organs; 2020 Sep; 44(9):939-946. PubMed ID: 32302423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome.
    Kim J; Feller ED; Chen W; Liang Y; Dilsizian V
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):722-729. PubMed ID: 29550312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive occult infection of a left ventricular assist device with Candida albicans.
    Sabashnikov A; Mohite PN; Zych B; Popov AF; Garcia D; Simon AR
    Artif Organs; 2013 Jun; 37(6):582-3. PubMed ID: 23638703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.